Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126778971 | 12677897 | 1 | I | 201602 | 20160212 | 20160823 | 20160823 | PER | US-TARO-2016TAR00163 | TARO | 64.83 | YR | M | Y | 85.71000 | KG | 20160811 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126778971 | 12677897 | 1 | PS | WARFARIN SODIUM TABLETS USP 5MG | WARFARIN SODIUM | 1 | Oral | 5 MG, 1X/DAY | 40301 | 5 | MG | TABLET | QD | ||||||
126778971 | 12677897 | 2 | SS | WARFARIN SODIUM TABLETS USP 5MG | WARFARIN SODIUM | 1 | Oral | 5 MG, 1X/DAY | 40301 | 5 | MG | TABLET | QD | ||||||
126778971 | 12677897 | 3 | SS | WARFARIN SODIUM TABLETS USP 5MG | WARFARIN SODIUM | 1 | Oral | 7.5 MG, 1X/DAY | 40301 | 7.5 | MG | TABLET | QD | ||||||
126778971 | 12677897 | 4 | SS | AMIODARONE HCL TABLET 200 MG | AMIODARONE HYDROCHLORIDE | 1 | Oral | 1 TABLETS, 2X/DAY | 0 | 1 | DF | TABLET | BID | ||||||
126778971 | 12677897 | 5 | C | COREG | CARVEDILOL | 1 | UNK, 2X/DAY | 0 | BID | ||||||||||
126778971 | 12677897 | 6 | C | POTASSIUM | POTASSIUM | 1 | UNK, 1X/DAY | 0 | QD | ||||||||||
126778971 | 12677897 | 7 | C | HAWTHORN | CRATAEGUS LAEVIGATA FRUIT | 1 | UNK, 1X/DAY | 0 | QD | ||||||||||
126778971 | 12677897 | 8 | C | COZAAR | LOSARTAN POTASSIUM | 1 | UNK, 2X/DAY | 0 | BID | ||||||||||
126778971 | 12677897 | 9 | C | COQ10 | UBIDECARENONE | 1 | UNK, 1X/DAY | 0 | QD | ||||||||||
126778971 | 12677897 | 10 | C | MAGNESIUM | MAGNESIUM | 1 | UNK, 1X/DAY | 0 | QD | ||||||||||
126778971 | 12677897 | 11 | C | LASIX | FUROSEMIDE | 1 | UNK, AS NEEDED | 0 | |||||||||||
126778971 | 12677897 | 12 | C | JUICE PLUS | DIETARY SUPPLEMENT | 1 | UNK, 1X/DAY | 0 | QD | ||||||||||
126778971 | 12677897 | 13 | C | BIOPLASMA | HOMEOPATHICS | 1 | UNK, 1X/DAY | 0 | BID | ||||||||||
126778971 | 12677897 | 14 | C | OMEGA 3 | OMEGA-3 FATTY ACIDS | 1 | UNK, 1X/DAY | 0 | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126778971 | 12677897 | 1 | Atrial fibrillation |
126778971 | 12677897 | 4 | Atrial fibrillation |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126778971 | 12677897 | Drug interaction | |
126778971 | 12677897 | International normalised ratio fluctuation |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126778971 | 12677897 | 1 | 201602 | 0 | ||
126778971 | 12677897 | 2 | 20160201 | 201602 | 0 | |
126778971 | 12677897 | 3 | 201602 | 201602 | 0 | |
126778971 | 12677897 | 4 | 201601 | 0 |